<code id='71DD3019DD'></code><style id='71DD3019DD'></style>
    • <acronym id='71DD3019DD'></acronym>
      <center id='71DD3019DD'><center id='71DD3019DD'><tfoot id='71DD3019DD'></tfoot></center><abbr id='71DD3019DD'><dir id='71DD3019DD'><tfoot id='71DD3019DD'></tfoot><noframes id='71DD3019DD'>

    • <optgroup id='71DD3019DD'><strike id='71DD3019DD'><sup id='71DD3019DD'></sup></strike><code id='71DD3019DD'></code></optgroup>
        1. <b id='71DD3019DD'><label id='71DD3019DD'><select id='71DD3019DD'><dt id='71DD3019DD'><span id='71DD3019DD'></span></dt></select></label></b><u id='71DD3019DD'></u>
          <i id='71DD3019DD'><strike id='71DD3019DD'><tt id='71DD3019DD'><pre id='71DD3019DD'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:27
          Illustration of doctors and researchers using innovative technologies for medicine and healthcare with artificial intelligence. -- health tech coverage from STAT
          Adobe

          At first glance, the Coalition for Health AI looks like any technology lobbying group. Its membership — including Microsoft, Google, and many of the nation’s largest academic hospitals — forms a formidable presence in Washington.

          But on Monday, the coalition forged a different deal with federal regulators. It will work with them to develop quality and safety standards for artificial intelligence, an experiment that will test whether industry and government can effectively partner in the regulation of a fast-moving technology.

          advertisement

          The nonprofit announced that its board of directors will include leaders from the Food and Drug Administration and the Office of the National Coordinator for Health Information Technology — agencies that, until now, have been setting up guardrails for AI in health care on their own. Government staffers will now work alongside industry scientists to develop evaluation methods and address new questions posed by generative AI and its emerging applications.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati
          In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

          CourtesyBristolMyersSquibbBristolMyersSquibbsaidthatitwouldpurchaseMiratiTherapeutics,makerofthecanc

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          FDA panel signals lack of confidence in Amgen cancer drug data

          AdobeTheclearanceofafirst-of-its-kindcancertreatmentmadebyAmgenisonshakiergroundfollowingaFoodandDru